Indication creep’ and increasing financial toxicity to patients remain of significant concern, cautions Michelle Kittleson.
STROKE-AF’s extended follow-up suggests short-term monitoring isn’t enough, but the significance of any AF found is unknown.
However, preprocedural antianginal therapy or stress testing might not be “optimal” for several reasons, says Lorenzo ...
The hope is that low-risk patients could avoid the ED, while those with ACS would be sent directly to PCI-capable hospitals.
Intermediate- and high-risk surgical cases declined while lower-risk cases increased, possibly explaining a boost in outcomes ...
The AHA’s initiative has raised awareness and funded research, but even its strongest supporters see room to grow.
The increase was independent of traditional CV risk factors and argues for efforts to target inadequate access to nutrition.
The motive for doing so is unbiased patient care, say those involved, but surgeons’ surgical volumes could also increase.
Heightened awareness about risk after a sepsis hospitalization may change treatment and follow-up plans, the authors say.
The CMS decision to decouple LVAD-only centers from transplant centers is having unintended consequences, experts say.
Pooled data from several pivotal trials suggests more patients with intraventricular conduction delays should get treated.
The STS registry results bring yet another argument against the downgrade of CABG in the 2021 revascularization guidelines.